Altered transcriptional regulation is a major contributor to the neoplastic characteristics of most tumor cells. New technological advances, such as DNA microchips, have allowed investigators to perform large scale comparisons of gene expression differences in normal versus cancer cells. However, there many unanswered questions concerning the transcription factors which are altered in cancers, their target genes, and the mechanisms by which transcriptional regulation is achieved. We have chosen to focus on three families of transcription factors due to extensive evidence linking them to the control of cell proliferation. E217 factors control genes involved in DNA synthesis and cell cycle progression and regulators of this family are mutated in the majority of human tumors. The Myc family has also been implicated in the development of many cancers and Myc factors regulate genes required for DNA and protein synthesis and telomere maintenance. Finally, the TCF family of transcription factors, in cooperation with beta-catenin, is thought to be a major contributor in the development of colon cancer, a leading cause of cancer death in the U.S.
In Aim I, we propose to investigate whether current models of transcriptional regulation accu- rately reflect gene expression mediated by these factors. We will do so by determining if all S phase cells display identical gene expression profiles (using in situ hybridizations and reporter assays) and by deter- mining if complexes containing different members of the E2F, Myc, or TCF families are functionally equivalent (using a chromatin immunoprecipitation assay which monitors DNA/protein interactions in living cells).
In Aim II, We propose to compare transcriptional regulation by these factors in cell cultures versus human tumors. For these experiments, we have recently demonstrated that our chromatin immunoprecipitation assay can directly monitor transcription factor binding to target promoters in surgical samples. Finally, in Aim III, we propose to modify our chromatin immunoprecipitation assay to identify novel target genes regulated by the E2F, Myc, and TCF factors in normal and cancer cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA045240-17
Application #
6769530
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Mietz, Judy
Project Start
1987-04-01
Project End
2004-08-31
Budget Start
2004-07-01
Budget End
2004-08-31
Support Year
17
Fiscal Year
2004
Total Cost
$173,767
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Kennedy, Brian A; Lan, Xun; Huang, Tim H-M et al. (2012) Using ChIPMotifs for de novo motif discovery of OCT4 and ZNF263 based on ChIP-based high-throughput experiments. Methods Mol Biol 802:323-34
Iyengar, Sushma; Farnham, Peggy J (2011) KAP1 protein: an enigmatic master regulator of the genome. J Biol Chem 286:26267-76
Iyengar, Sushma; Ivanov, Alexey V; Jin, Victor X et al. (2011) Functional analysis of KAP1 genomic recruitment. Mol Cell Biol 31:1833-47
Cao, Alina R; Rabinovich, Roman; Xu, Maoxiong et al. (2011) Genome-wide analysis of transcription factor E2F1 mutant proteins reveals that N- and C-terminal protein interaction domains do not participate in targeting E2F1 to the human genome. J Biol Chem 286:11985-96
Frietze, Seth; Lan, Xun; Jin, Victor X et al. (2010) Genomic targets of the KRAB and SCAN domain-containing zinc finger protein 263. J Biol Chem 285:1393-403
O'Geen, Henriette; Frietze, Seth; Farnham, Peggy J (2010) Using ChIP-seq technology to identify targets of zinc finger transcription factors. Methods Mol Biol 649:437-55
Blahnik, Kimberly R; Dou, Lei; O'Geen, Henriette et al. (2010) Sole-Search: an integrated analysis program for peak detection and functional annotation using ChIP-seq data. Nucleic Acids Res 38:e13
Krig, S R; Miller, J K; Frietze, S et al. (2010) ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells. Oncogene 29:5500-10
Farnham, Peggy J (2009) Insights from genomic profiling of transcription factors. Nat Rev Genet 10:605-16
Acevedo, Luis G; Bieda, Mark; Green, Roland et al. (2008) Analysis of the mechanisms mediating tumor-specific changes in gene expression in human liver tumors. Cancer Res 68:2641-51

Showing the most recent 10 out of 15 publications